Chronic Respiratory Disease Mortality Up From 1980 to 2014

Share this content:
Chronic Respiratory Disease Mortality Up From 1980 to 2014
Chronic Respiratory Disease Mortality Up From 1980 to 2014

TUESDAY, Sept. 26, 2017 (HealthDay News) -- From 1980 to 2014 there was a considerable increase in mortality from chronic respiratory diseases in the United States, according to a study published in the Sept. 26 issue of the Journal of the American Medical Association.

Laura Dwyer-Lindgren, M.P.H., from the University of Washington in Seattle, and colleagues estimated age-standardized mortality rates by county from chronic respiratory diseases using death records from the National Center for Health Statistics and population counts from the U.S. Census Bureau, National Center for Health Statistics, and Human Mortality Database for 1980 to 2014.

The researchers found that from 1980 through 2014, 4,616,711 deaths due to chronic respiratory disease were recorded in the United States. Nationwide, there was an increase in the mortality rate from chronic respiratory diseases, from 40.8 deaths per 100,000 population in 1980 to a peak of 55.4 deaths per 100,000 population in 2002, and a decrease to 52.9 deaths per 100,000 population in 2014. This 29.7 percent increase from 1980 to 2014 reflected increases in the mortality rate from chronic obstructive pulmonary disease (by 30.8 percent), from interstitial lung disease and pulmonary sarcoidosis (by 100.5 percent), and from all other chronic respiratory diseases (by 42.3 percent). Among counties, there were substantial differences in mortality rates and changes in mortality rates over time; geographic patterns varied by cause.

"These estimates may be helpful for informing efforts to improve prevention, diagnosis, and treatment," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »